Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Balaji Amines manufactures aliphatic amines (methylamines, ethylamines), amine derivatives and specialty chemicals such as DMF, DMA-HCl, morpholine and NMP, which serve pharmaceutical, agrochemical, and industrial end-markets. It also operates a subsidiary, Balaji Speciality Chemicals, producing ethylenediamine and related niche products, and earnings are sensitive to methanol/ammonia input costs and pharma/agro demand cycles. A hotel property in Solapur is a minor ancillary asset.
One of India's two dominant aliphatic amines producers alongside Alkyl Amines.
Balaji Amines Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Balaji Amines Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 51.60 | 48.62 | 63.22 |
| Book value / share (₹) | — | 622.94 | 584.32 |
| Return on equity | 7.9% | 7.8% | 10.6% |
| Return on capital employed | 8.9% | 8.7% | 13.9% |
| Operating margin | 14.7% | 13.2% | 17.0% |
| Net margin | 11.9% | 11.3% | 14.2% |
| EBITDA | ₹265 Cr | ₹232 Cr | ₹324 Cr |
| Free cash flow | ₹-186 Cr | ₹69 Cr | ₹-35 Cr |
| Total debt | ₹133 Cr | ₹11 Cr | ₹20 Cr |
| Debt to equity | 0.06 | 0.01 | 0.01 |
| Interest coverage | 38.9 | 49.7 | 43.2 |
| Current ratio | 2.34 | 7.26 | 6.70 |
| Shares outstanding | — | 3,24,01,000 | 3,24,01,000 |
Open the full income statement, balance sheet and cash flow for BALAMINES →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.